Gene-expression profiles in CD34 cells treated with IFN-γ in vitro compared with expression profiles in bone marrow failure states
. | . | . | MDS . | . | . | . | PNH . | . | ||
---|---|---|---|---|---|---|---|---|---|---|
GenBank no. . | Gene name . | IFN-γ treated . | –7 . | +8 . | AA . | GPI-D . | GPI-N . | GPI-N vs GPI-D . | ||
Similarly altered genes | ||||||||||
Apoptosis genes | ||||||||||
X63717† | FAS* | ↑4 | – | – | ↑ | – | ↑ | ↑ | ||
U37518† | TRAIL* | ↑20 | ↑ | – | ↑ | – | ↑ | – | ||
X98175 | CASP8* | ↑20 | ↑ | – | – | – | – | – | ||
M92357†† | B94, TNFα-induced protein 2 | ↑20 | ↑ | ↑ | ↑ | – | – | – | ||
Y16961 | Tumor protein, 63 kDa, with strong homology to p53 | ↑20 | ↑ | ↑ | – | – | – | – | ||
U43746 | Breast cancer 2, early onset | ↑20 | ↑ | – | – | – | – | – | ||
X04434 | Insulin-like growth factor 1 receptor | ↑20 | – | ↑ | – | – | – | – | ||
M31165† | TNFα-induced protein 6 | ↑20 | – | – | ↑ | – | – | – | ||
AF061034† | Optineurin | ↑20 | – | – | ↑ | – | – | – | ||
AF005775 | CFLAR | ↑20 | – | – | ↑ | – | ↑ | – | ||
Cytokines/chemokines and receptors | ||||||||||
X02910 | TNF | ↑20 | – | – | ↑ | – | ↑ | ↑ | ||
U00672 | IL10RA* | ↑20 | – | ↑ | ↑ | – | – | – | ||
M21121 | CCL5* | ↑20 | – | – | ↑ | – | ↑ | ↑ | ||
Y16645† | CCL8* | ↑20 | – | ↑ | – | – | ↑ | ↑ | ||
AF030514† | CXCL11* | ↑20 | – | – | – | – | ↑ | ↑ | ||
X72755† | CXCL9* | ↑4, ↑40 | – | – | – | – | ↑ | ↑ | ||
X02530† | CXCL10* | ↑4, ↑40 | – | – | – | – | – | ↑ | ||
Cell adhesion | ||||||||||
M30257 | VCAM1 | ↑20 | – | ↑ | – | – | – | – | ||
U88964† | IS320 | ↑20 | – | – | ↑ | – | ↑ | – | ||
M63193† | EGF1 | ↑20 | – | – | ↑ | – | – | – | ||
M73255† | VCAM1 | ↑20 | – | – | ↑ | – | – | – | ||
Cell growth and maintenance | ||||||||||
AF044309 | Syntaxin 11 | ↑20 | – | – | – | – | ↑ | – | ||
X57522† | Transporter 1 (MDR/TAP)* | ↑20 | – | – | – | – | ↑ | – | ||
M77016 | Tropomodulin 1 | ↑20 | – | – | – | ↑ | – | – | ||
U20982 | Insulin-like growth factor-binding protein 4 | ↑20 | – | – | – | – | – | ↑ | ||
J04164† | IFM1 (9-27)* | ↑20, ↑20 | – | – | ↑ | – | ↑ | – | ||
X59892† | Tryptophanyl-tRNA synthetase* | ↑20, ↑20 | – | – | – | – | ↑ | ↑ | ||
Signal transduction | ||||||||||
U02020† | Pre–B-cell colony-enhancing factor 1 | ↑4 | – | – | ↑ | – | ↑ | – | ||
D10923 | Putative chemokine receptor | ↑4 | – | – | – | – | ↑ | – | ||
M97935† | STAT1* | ↑20 | – | – | ↑ | – | – | ↑ | ||
Immune response | ||||||||||
X16354† | Carcinoembryonic antigen-related cell-adhesion molecule 1* | ↑4 | – | – | ↑ | – | – | – | ||
M55543† | GBP2 | ↑20 | – | – | ↑ | – | ↑ | ↑ | ||
M55542† | GBP1 | ↑20 | – | – | – | – | ↑ | ↑ | ||
M13755† | GIP2 | ↑4, ↑20 | – | – | – | – | ↑ | – | ||
Transcription factor | ||||||||||
L19871† | Activating transcription factor 3* | ↑4 | – | – | – | – | ↑ | – | ||
Contradictory expression genes | ||||||||||
U64198 | IL12RB2* | ↑4 | – | – | ↓ | ↓ | – | – | ||
M36820† | CXCL2* | ↓4 | – | – | ↑ | – | ↑ | ↑ | ||
M36821† | CXCL3* | ↓4 | – | – | ↑ | – | ↑ | ↑ | ||
AF043129 | IL-7R | ↓4, ↓20 | – | ↑ | ↑ | – | ↑ | ↑ | ||
M27492 | IL-1R1 | ↓4, ↓20 | – | – | ↑ | – | – | – |
. | . | . | MDS . | . | . | . | PNH . | . | ||
---|---|---|---|---|---|---|---|---|---|---|
GenBank no. . | Gene name . | IFN-γ treated . | –7 . | +8 . | AA . | GPI-D . | GPI-N . | GPI-N vs GPI-D . | ||
Similarly altered genes | ||||||||||
Apoptosis genes | ||||||||||
X63717† | FAS* | ↑4 | – | – | ↑ | – | ↑ | ↑ | ||
U37518† | TRAIL* | ↑20 | ↑ | – | ↑ | – | ↑ | – | ||
X98175 | CASP8* | ↑20 | ↑ | – | – | – | – | – | ||
M92357†† | B94, TNFα-induced protein 2 | ↑20 | ↑ | ↑ | ↑ | – | – | – | ||
Y16961 | Tumor protein, 63 kDa, with strong homology to p53 | ↑20 | ↑ | ↑ | – | – | – | – | ||
U43746 | Breast cancer 2, early onset | ↑20 | ↑ | – | – | – | – | – | ||
X04434 | Insulin-like growth factor 1 receptor | ↑20 | – | ↑ | – | – | – | – | ||
M31165† | TNFα-induced protein 6 | ↑20 | – | – | ↑ | – | – | – | ||
AF061034† | Optineurin | ↑20 | – | – | ↑ | – | – | – | ||
AF005775 | CFLAR | ↑20 | – | – | ↑ | – | ↑ | – | ||
Cytokines/chemokines and receptors | ||||||||||
X02910 | TNF | ↑20 | – | – | ↑ | – | ↑ | ↑ | ||
U00672 | IL10RA* | ↑20 | – | ↑ | ↑ | – | – | – | ||
M21121 | CCL5* | ↑20 | – | – | ↑ | – | ↑ | ↑ | ||
Y16645† | CCL8* | ↑20 | – | ↑ | – | – | ↑ | ↑ | ||
AF030514† | CXCL11* | ↑20 | – | – | – | – | ↑ | ↑ | ||
X72755† | CXCL9* | ↑4, ↑40 | – | – | – | – | ↑ | ↑ | ||
X02530† | CXCL10* | ↑4, ↑40 | – | – | – | – | – | ↑ | ||
Cell adhesion | ||||||||||
M30257 | VCAM1 | ↑20 | – | ↑ | – | – | – | – | ||
U88964† | IS320 | ↑20 | – | – | ↑ | – | ↑ | – | ||
M63193† | EGF1 | ↑20 | – | – | ↑ | – | – | – | ||
M73255† | VCAM1 | ↑20 | – | – | ↑ | – | – | – | ||
Cell growth and maintenance | ||||||||||
AF044309 | Syntaxin 11 | ↑20 | – | – | – | – | ↑ | – | ||
X57522† | Transporter 1 (MDR/TAP)* | ↑20 | – | – | – | – | ↑ | – | ||
M77016 | Tropomodulin 1 | ↑20 | – | – | – | ↑ | – | – | ||
U20982 | Insulin-like growth factor-binding protein 4 | ↑20 | – | – | – | – | – | ↑ | ||
J04164† | IFM1 (9-27)* | ↑20, ↑20 | – | – | ↑ | – | ↑ | – | ||
X59892† | Tryptophanyl-tRNA synthetase* | ↑20, ↑20 | – | – | – | – | ↑ | ↑ | ||
Signal transduction | ||||||||||
U02020† | Pre–B-cell colony-enhancing factor 1 | ↑4 | – | – | ↑ | – | ↑ | – | ||
D10923 | Putative chemokine receptor | ↑4 | – | – | – | – | ↑ | – | ||
M97935† | STAT1* | ↑20 | – | – | ↑ | – | – | ↑ | ||
Immune response | ||||||||||
X16354† | Carcinoembryonic antigen-related cell-adhesion molecule 1* | ↑4 | – | – | ↑ | – | – | – | ||
M55543† | GBP2 | ↑20 | – | – | ↑ | – | ↑ | ↑ | ||
M55542† | GBP1 | ↑20 | – | – | – | – | ↑ | ↑ | ||
M13755† | GIP2 | ↑4, ↑20 | – | – | – | – | ↑ | – | ||
Transcription factor | ||||||||||
L19871† | Activating transcription factor 3* | ↑4 | – | – | – | – | ↑ | – | ||
Contradictory expression genes | ||||||||||
U64198 | IL12RB2* | ↑4 | – | – | ↓ | ↓ | – | – | ||
M36820† | CXCL2* | ↓4 | – | – | ↑ | – | ↑ | ↑ | ||
M36821† | CXCL3* | ↓4 | – | – | ↑ | – | ↑ | ↑ | ||
AF043129 | IL-7R | ↓4, ↓20 | – | ↑ | ↑ | – | ↑ | ↑ | ||
M27492 | IL-1R1 | ↓4, ↓20 | – | – | ↑ | – | – | – |